M&A Deal Summary

Merck Acquires Acceleron Pharma

On September 30, 2021, Merck acquired life science company Acceleron Pharma for 11.5B USD

Acquisition Highlights
  • This is Merck’s 25th transaction in the Life Science sector.
  • This is Merck’s 2nd largest (disclosed) transaction.
  • This is Merck’s 22nd transaction in the United States.
  • This is Merck’s 7th transaction in Massachusetts.

M&A Deal Summary
Date 2021-09-30
Target Acceleron Pharma
Sector Life Science
Buyer(s) Merck
Deal Type Add-on Acquisition
Deal Value 11.5B USD
Advisor(s) Centerview Partners
J.P. Morgan Securities (Financial)
Ropes & Gray (Legal)

Target

Acceleron Pharma

Cambridge, Massachusetts, United States
Acceleron Pharma is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. Acceleron Pharma was formed in 2003 and is based in Cambridge, Massachusetts.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Merck

Rahway, New Jersey, United States
Category Company
Founded 1891
Sector Life Science
Employees70,000
Revenue 60.1B USD (2023)
DESCRIPTION
Merck office in Palo Alto, California.
Merck office in Palo Alto, California.

Merck is a global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments. These include Pharmaceutical, Animal Health, Consumer Care and Alliances. Merck's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.

DEAL STATS #
Overall 28 of 35
Sector (Life Science) 25 of 32
Type (Add-on Acquisition) 27 of 33
State (Massachusetts) 7 of 8
Country (United States) 22 of 27
Year (2021) 2 of 2
Size (of disclosed) 2 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-03 Organon

Jersey City, New Jersey, United States

Organon develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health. Organon is based in Jersey City, New Jersey.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-21 Imago BioSciences

South San Francisco, California, United States

Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. Imago BioSciences was formed in 2012 and is based in South San Francisco, California.

Buy $1.4B
Mergr

Product

Company

Legal